Market Overview

S-3 from Galectin Therapeutics Shows Registration for $100M in Common Shares

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Offerings

 

Related Articles (GALT)

Loading...